A detailed history of Handelsbanken Fonder Ab transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 72,700 shares of IOVA stock, worth $427,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,700
Previous 74,800 2.81%
Holding current value
$427,476
Previous $702,000 23.36%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

SELL
$7.17 - $12.28 $15,057 - $25,788
-2,100 Reduced 2.81%
72,700 $538,000
Q3 2024

Oct 04, 2024

BUY
$7.28 - $11.9 $83,720 - $136,850
11,500 Added 18.17%
74,800 $702,000
Q2 2024

Aug 05, 2024

SELL
$7.78 - $14.19 $1.21 Million - $2.21 Million
-155,600 Reduced 71.08%
63,300 $508,000
Q1 2024

May 13, 2024

BUY
$7.59 - $17.47 $1.24 Million - $2.85 Million
163,200 Added 293.0%
218,900 $3.24 Million
Q4 2023

Feb 01, 2024

BUY
$3.3 - $8.89 $87,450 - $235,585
26,500 Added 90.75%
55,700 $453,000
Q2 2023

Aug 02, 2023

BUY
$5.36 - $9.06 $23,048 - $38,958
4,300 Added 17.27%
29,200 $206,000
Q4 2020

Feb 11, 2021

BUY
$28.04 - $50.26 $123,376 - $221,144
4,400 Added 21.46%
24,900 $1.16 Million
Q2 2020

Aug 13, 2020

BUY
$27.21 - $41.0 $557,805 - $840,500
20,500 New
20,500 $563,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $928M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.